MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

SCA5 – A new Cause of Parkinsonism?

Y. Trufanov, N. Svyrydova, A. Galusha (Kyiv, Ukraine)

Meeting: 2022 International Congress

Abstract Number: 432

Keywords: Parkinsonism, Spinocerebellar ataxia, Spinocerebellar ataxias(SCA)

Category: Ataxia

Objective: To provide a description of a case of a young patient with atypical Parkinsonism with a mutation in SCA5.

Background: While several scpinocerebellar ataxias are known to present with levodopa responsive Parkinsonism, little is known about SCA5.

Method: Clinical description and laboratory testing.

Results: For the last 5 years, we have been following a 40-year-old patient with Parkinsonism with onset at 33 years. This began with right sided bradykinesia.
Family history revealed his paternal grandfather had been diagnosed with PD.
Currently he complains of difficulty using his right hand, dragging his right leg, and sometimes slight unsteadiness; also right arm tremor, and muscle pain during off periods, frequent urination and occasional depression.
He is on levodopa (750 mg daily) a 50% – 70% reduction in symptoms. Mild dyskinesaias are present.
On examination (off time) a severe asymmetry of motor symptoms was noteworthy with severe bradykinesia and muscle rigidity on the right and mild on the left. There was moderate rest tremor on right arm and slight kinetic tremor of both arms. Cognitive functions were completely normal. He had frequent urination and there were no other autonomic abnormalities. The rest of the neurologic exam was normal.
Laboratory blood tests were normal (including ceruloplasmin, urine copper and liver tests). MRI of brain was normal.
Whole exome sequencing at the UCL Institute of Neurology Queen Square showed: SPTBN2 (ENST00000309996), c.548T>G, p.Leu183Arg c.548T>G in SPTBN2 has an ultra-rare MAF in gnomAD and is predicted to be damaging and deleterious by SIFT and Polyphen. No abnormalities were found in genes associated with Parkinson disease.

Conclusion: This patient presents with rapidly progressive Parkinsonism, and a mutation in the gene for SCA5. At this time, there is no evidence of cerebellar abnormalities. This type of presentation has been reported previously in both SCA2 and 3 with cerebellar abnormalities presenting much later in the course of the disease.

To cite this abstract in AMA style:

Y. Trufanov, N. Svyrydova, A. Galusha. SCA5 – A new Cause of Parkinsonism? [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/sca5-a-new-cause-of-parkinsonism/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/sca5-a-new-cause-of-parkinsonism/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley